Your browser doesn't support javascript.
loading
18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis.
Ederhy, Stéphane; Devos, Perrine; Pinna, Bruno; Funck-Brentano, Elisa; Abbar, Baptiste; Fenioux, Charlotte; Cohen, Ariel A; Moslehi, Javid; Bretagne, Marie; Allenbach, Yves; Kharroubi, Dris; Salem, Joe-Elie.
Afiliação
  • Ederhy S; Department of cardiology, Saint-Antoine Hospital, Sorbonne université, AP-HP, 75012 Paris, France; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France.
  • Devos P; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France; Department of cardiology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Pinna B; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France; Inserm CIC-1901, department of pharmacology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Funck-Brentano E; Department of general and oncologic dermatology, Ambroise-Paré hospital, AP-HP, 92100 Boulogne-Billancourt, France; Inserm EA4340, Paris-Saclay university, 92104 Boulogne-Billancourt, France.
  • Abbar B; Inserm CIC-1901, department of pharmacology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Fenioux C; Inserm CIC-1901, department of pharmacology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Cohen AA; Department of cardiology, Saint-Antoine Hospital, Sorbonne université, AP-HP, 75012 Paris, France; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France.
  • Moslehi J; Department of medicine, Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Bretagne M; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France; Inserm CIC-1901, department of pharmacology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Allenbach Y; Department of internal medicine, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Kharroubi D; Department of nuclear medicine, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France.
  • Salem JE; UNICO-GRECO cardio-oncology program, Sorbonne université, AP-HP, 75013 Paris, France; Department of cardiology, Pitié-Salpêtrière hospital, Sorbonne université, AP-HP, 75013 Paris, France; Department of medicine, Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Arch Cardiovasc Dis ; 115(2): 114-116, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35120869
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Miocardite Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Miocardite Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article